Advertisement
UK markets close in 3 hours 11 minutes
  • FTSE 100

    8,098.30
    +57.92 (+0.72%)
     
  • FTSE 250

    19,731.93
    +12.56 (+0.06%)
     
  • AIM

    755.57
    +0.88 (+0.12%)
     
  • GBP/EUR

    1.1667
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2503
    +0.0040 (+0.32%)
     
  • Bitcoin GBP

    51,160.25
    -2,143.87 (-4.02%)
     
  • CMC Crypto 200

    1,356.80
    -25.77 (-1.86%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.15
    +0.34 (+0.41%)
     
  • GOLD FUTURES

    2,340.90
    +2.50 (+0.11%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,996.80
    -91.90 (-0.51%)
     
  • CAC 40

    8,023.60
    -68.26 (-0.84%)
     

Analysts’ Recommendations for Novartis on April 17

Analysts’ Recommendations for Novartis on April 17

Novartis AG (NVS) reported revenue of $12.9 billion and EPS (earnings per share) of $1.21 in 4Q17, a 4.8% rise in revenue compared to 4Q16. For 1Q18, analysts expect Novartis to see EPS of $1.28 on revenue of $12.6 billion.